Just finished reading this months AARP Bulletin. There is a short article in it reporting John Hopkins has developed a new blood test for prostate cancer. The new test reduces the amount of false positive biopsies. According to the article biospies done due to the PSA blood test average 80% false positives. The new blood test, EPSA-2, in testing had a 3% false positive rate. EPSA-2 stands for Early Prostate Specitic Antigen - 2. I wonder if that new test has been standardized in the medical community. Those on this forum should pass this along to those that post here prior to having a biopsy.